tirzepatide fda approval 2022 The long awaited twincretin was just approved on Friday for type 2 diabetes! 💊 Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP What happens next following FDA

Frontier Peptide Labs supplies PT-141 Liquid Spray exclusively for qualified laboratory professionals conducting scientific investigation

Accelerating the titration schedule is not recommended

GLP-1 Market Share, By End User, 2025 (%) The hospitals segment held a 19% share of the market in 2025 and is expected to grow at a CAGR of 8.4% during the projection period

You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings

Compounded semaglutide in four formats (injection, oral tablet, oral drops, and microdose), compounded tirzepatide injections, plus brand-name options Ozempic, Mounjaro, Wegovy, Zepbound, Rybelsus, and more